相关实验视频
Updated: Jul 26, 2026

05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
在快速耗尽托芬后,抑郁症的复发
K A Smith1, C G Fairburn, P J Cowen
1University Department of Psychiatry, Littlemore Hospital, Oxford, UK.
Lancet (London, England)
|March 29, 1997
概括
通过耗尽托来降低大脑的血清激素活性,在容易患重度抑郁症的女性中暂时引发了抑郁症状. 这支了血清的作用.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 生物化学 生物化学
背景情况:
- 大型抑郁症的病理生理学仍然不清楚,尽管涉及到血清的途径.
- 选择性血清素再吸收抑制剂 (SSRI) 是有效的抗抑郁药,这表明血清素有作用.
- 缺乏直接证据将降低的血清素功能与抑郁症发作联系在一起.
研究的目的:
- 为了调查急性托芬枯竭是否会在易患重度抑郁症的个体中引起抑郁症状.
- 探索色胺功能的因果作用在抑郁症的病因学.
主要方法:
- 这是一项双盲交叉研究,涉及15名有复发性抑郁病史的女性.
- 参与者食用了两个氨基酸混合物:一个平衡的,一个没有托芬的.
- 用汉密尔顿抑郁症评分表 (HAMD) 和自我评分情绪表来评估抑郁症症状.
主要成果:
- 托芬枯竭显著降低了75%的血托芬水平.
- 在15名参与者中,有10人经历了临床显著的抑郁症状,后消费了无托混合物.
- 与平衡混合物相比,在托耗尽后,HAMD得分显著增加.
结论:
- 大脑中血清功能的急性减少可以在脆弱的个体中加速抑郁症状.
- 这些发现提供了证据,证明血清素功能缺陷在抑郁症发展中的关键作用.
更多相关视频
相关概念视频
G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...
Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
![Radiosynthesis of 1-(2-[18F]Fluoroethyl)-L-Tryptophan using a One-pot, Two-step Protocol](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F63025.jpg&w=3840&q=50)
